Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT

NCT04738981 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
130
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Peking University People's Hospital

Collaborators